{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "dementia", "formononetin", "neuroinflammation", "neurological disorders", "nociception", "oxidative stress", "traumatic brain injury"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35712702", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "30"}], "Language": ["eng"], "ELocationID": ["905898", "10.3389/fphar.2022.905898"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials.", "Pagination": {"StartPage": "905898", "MedlinePgn": "905898"}, "Abstract": {"AbstractText": ["Nervous system is the most complex system of the human body, hence, the neurological diseases often lack effective treatment strategies. Natural products have the potential to yield unique molecules and produce integrative and synergic effects compared to standard therapy. Mounting evidence has shown that isoflavonoids contained in traditional medicinal plant or dietary supplementation may play a crucial role in the prevention and treatment of neurological diseases due to their pronounced biological activities correlating to nervous system. Formononetin, a non-steroidal isoflavonoid, is a bioactive constituent of numerous medicinal plants such as red clover (<i>Trifolium pratense</i>) and <i>Astragalus membranaceus.</i> Emerging evidence has shown that formononetin possesses considerable anti-inflammatory, antioxidant and anti-cancer effects. This review intends to analyze the neuropharmacological potential of formononetin on the therapy of nervous system disorders. The neuroprotective properties of formononetin are observed in multiple neurological disorders including Alzheimer's disease, dementia, cerebral ischemia, traumatic brain injury, anxiety, and depression. The beneficial effects of formononetin are achieved partially through attenuating neuroinflammation and oxidative stress <i>via</i> the related signaling pathway. Despite its evident effects in numerous preclinical studies, the definite role of formononetin on humans is still less known. More well-designed clinical trials are required to further confirm the neuroprotective efficacy and safety profile of formononetin before its application in clinic."], "CopyrightInformation": "Copyright \u00a9 2022 Tian, Wang and Tian."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Infection, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China."}, {"Identifier": [], "Affiliation": "Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, China."}], "LastName": "Tian", "ForeName": "Jiao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China."}], "LastName": "Wang", "ForeName": "Xing-Qin", "Initials": "XQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, College of Pharmaceutical Sciences, Southwest University, Chongqing, China."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, China."}], "LastName": "Tian", "ForeName": "Zhen", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aly S. H., Elissawy A. M., Fayez A. M., Eldahshan O. A., Elshanawany M. A., Singab A. N. B. (2021). Neuroprotective Effects of Sophora Secundiflora, Sophora tomentosa Leaves and Formononetin on Scopolamine-Induced Dementia. Nat. Prod. Res. 35 (24), 5848\u20135852. 10.1080/14786419.2020.1795853", "ArticleIdList": ["10.1080/14786419.2020.1795853", "32696670"]}, {"Citation": "Alzheimer's A. (2016). 2016 Alzheimer's Disease Facts and Figures. Alzheimers Dement. 12 (4), 459\u2013509. 10.1016/j.jalz.2016.03.001", "ArticleIdList": ["10.1016/j.jalz.2016.03.001", "27570871"]}, {"Citation": "Andres S., Hansen U., Niemann B., Palavinskas R., Lampen A. (2015). Determination of the Isoflavone Composition and Estrogenic Activity of Commercial Dietary Supplements Based on Soy or Red Clover. Food Funct. 6 (6), 2017\u20132025. 10.1039/c5fo00308c", "ArticleIdList": ["10.1039/c5fo00308c", "26023053"]}, {"Citation": "Barnes S., Prasain J., D'Alessandro T., Arabshahi A., Botting N., Lila M. A., et al. (2011). The Metabolism and Analysis of Isoflavones and Other Dietary Polyphenols in Foods and Biological Systems. Food Funct. 2 (5), 235\u2013244. 10.1039/c1fo10025d", "ArticleIdList": ["10.1039/c1fo10025d", "PMC4122511", "21779561"]}, {"Citation": "Cassileth B. (2010). Complementary Therapies, Herbs, and Other OTC Agents: Red Clover (Trifolium Pratense). Oncol. Willist. Park) 24 (10), 960.", "ArticleIdList": ["21138179"]}, {"Citation": "Cederroth C. R., Nef S. (2009). Soy, Phytoestrogens and Metabolism: A Review. Mol. Cell. Endocrinol. 304 (1-2), 30\u201342. 10.1016/j.mce.2009.02.027", "ArticleIdList": ["10.1016/j.mce.2009.02.027", "19433245"]}, {"Citation": "Chen H. Q., Wang X. J., Jin Z. Y., Xu X. M., Zhao J. W., Xie Z. J. (2008). Protective Effect of Isoflavones from Trifolium Pratense on Dopaminergic Neurons. Neurosci. Res. 62 (2), 123\u2013130. 10.1016/j.neures.2008.07.001", "ArticleIdList": ["10.1016/j.neures.2008.07.001", "18675857"]}, {"Citation": "Chen J., Wang S., Jia X., Bajimaya S., Lin H., Tam V. H., et al. (2005). Disposition of Flavonoids via Recycling: Comparison of Intestinal versus Hepatic Disposition. Drug Metab. Dispos. 33 (12), 1777\u20131784. 10.1124/dmd.105.003673", "ArticleIdList": ["10.1124/dmd.105.003673", "16120792"]}, {"Citation": "Chen L., Ou S., Zhou L., Tang H., Xu J., Guo K. (2017). Formononetin Attenuates A\u03b225-35-Induced Cytotoxicity in HT22 Cells via PI3K/Akt Signaling and Non-amyloidogenic Cleavage of APP. Neurosci. Lett. 639, 36\u201342. 10.1016/j.neulet.2016.12.064", "ArticleIdList": ["10.1016/j.neulet.2016.12.064", "28034780"]}, {"Citation": "D'Archivio M., Filesi C., Var\u00ec R., Scazzocchio B., Masella R. (2010). Bioavailability of the Polyphenols: Status and Controversies. Int. J. Mol. Sci. 11 (4), 1321\u20131342. 10.3390/ijms11041321", "ArticleIdList": ["10.3390/ijms11041321", "PMC2871118", "20480022"]}, {"Citation": "Di Lorenzo C., Colombo F., Biella S., Stockley C., Restani P. (2021). Polyphenols and Human Health: The Role of Bioavailability. Nutrients 13 (1), 273. 10.3390/nu13010273", "ArticleIdList": ["10.3390/nu13010273", "PMC7833401", "33477894"]}, {"Citation": "Dinoff A., Herrmann N., Lanct\u00f4t K. L. (2017). Ceramides and Depression: A Systematic Review. J. Affect Disord. 213, 35\u201343. 10.1016/j.jad.2017.02.008", "ArticleIdList": ["10.1016/j.jad.2017.02.008", "28189963"]}, {"Citation": "Durand E., Chevignard M., Ruet A., Dereix A., Jourdan C., Pradat-Diehl P. (2017). History of Traumatic Brain Injury in Prison Populations: A Systematic Review. Ann. Phys. Rehabil. Med. 60 (2), 95\u2013101. 10.1016/j.rehab.2017.02.003", "ArticleIdList": ["10.1016/j.rehab.2017.02.003", "28359842"]}, {"Citation": "El-Bakoush A., Olajide O. A. (2018). Formononetin Inhibits Neuroinflammation and Increases Estrogen Receptor Beta (ER\u03b2) Protein Expression in BV2 Microglia. Int. Immunopharmacol. 61, 325\u2013337. 10.1016/j.intimp.2018.06.016", "ArticleIdList": ["10.1016/j.intimp.2018.06.016", "29913427"]}, {"Citation": "Fang Y., Ye J., Zhao B., Sun J., Gu N., Chen X., et al. (2020). Formononetin Ameliorates Oxaliplatin-Induced Peripheral Neuropathy via the KEAP1-NRF2-GSTP1 axis. Redox Biol. 36, 101677. 10.1016/j.redox.2020.101677", "ArticleIdList": ["10.1016/j.redox.2020.101677", "PMC7451796", "32823168"]}, {"Citation": "Fei H. X., Zhang Y. B., Liu T., Zhang X. J., Wu S. L. (2018). Neuroprotective Effect of Formononetin in Ameliorating Learning and Memory Impairment in Mouse Model of Alzheimer's Disease. Biosci. Biotechnol. Biochem. 82 (1), 57\u201364. 10.1080/09168451.2017.1399788", "ArticleIdList": ["10.1080/09168451.2017.1399788", "29191087"]}, {"Citation": "Fu X., Qin T., Yu J., Jiao J., Ma Z., Fu Q., et al. (2019). Formononetin Ameliorates Cognitive Disorder via PGC-1\u03b1 Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice. CNS Neurol. Disord. Drug Targets 18 (7), 566\u2013577. 10.2174/1871527318666190807160137", "ArticleIdList": ["10.2174/1871527318666190807160137", "31389320"]}, {"Citation": "Gampe N., D\u00e1vid D. N., Tak\u00e1cs-Nov\u00e1k K., Backlund A., B\u00e9ni S. (2022). In Vitro and In Silico Evaluation of Ononis Isoflavonoids as Molecules Targeting the Central Nervous System. PLoS One 17 (3), e0265639. 10.1371/journal.pone.0265639", "ArticleIdList": ["10.1371/journal.pone.0265639", "PMC8929578", "35298568"]}, {"Citation": "Geng L.-M., Jiang J.-G. (2022). The Neuroprotective Effects of Formononetin: Signaling Pathways and Molecular Targets. J. Funct. Foods 88, 104911. 10.1016/j.jff.2021.104911", "ArticleIdList": ["10.1016/j.jff.2021.104911"]}, {"Citation": "Gu Y., Chen X., Fu S., Liu W., Wang Q., Liu K.-J., et al. (2021). Astragali Radix Isoflavones Synergistically Alleviate Cerebral Ischemia and Reperfusion Injury via Activating Estrogen Receptor-Pi3k-Akt Signaling Pathway. Front. Pharmacol. 12, 533028. 10.3389/fphar.2021.533028", "ArticleIdList": ["10.3389/fphar.2021.533028", "PMC7937971", "33692686"]}, {"Citation": "Gunata M., Parlakpinar H., Acet H. A. (2020). Melatonin: A Review of its Potential Functions and Effects on Neurological Diseases. Rev. Neurol. Paris. 176 (3), 148\u2013165. 10.1016/j.neurol.2019.07.025", "ArticleIdList": ["10.1016/j.neurol.2019.07.025", "31718830"]}, {"Citation": "Hankey G. J. (2017). The Role of Nutrition in the Risk and Burden of Stroke: An Update of the Evidence. Stroke 48 (11), 3168\u20133174. 10.1161/STROKEAHA.117.016993", "ArticleIdList": ["10.1161/STROKEAHA.117.016993", "28939673"]}, {"Citation": "Howes J. B., Bray K., Lorenz L., Smerdely P., Howes L. G. (2004). The Effects of Dietary Supplementation with Isoflavones from Red Clover on Cognitive Function in Postmenopausal Women. Climacteric 7 (1), 70\u201377. 10.1080/13697130310001651490", "ArticleIdList": ["10.1080/13697130310001651490", "15259285"]}, {"Citation": "Jia X., Chen J., Lin H., Hu M. (2004). Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates. J. Pharmacol. Exp. Ther. 310 (3), 1103\u20131113. 10.1124/jpet.104.068403", "ArticleIdList": ["10.1124/jpet.104.068403", "15128864"]}, {"Citation": "Khawaja N., Abu-Shennar J., Saleh M., Dahbour S. S., Khader Y. S., Ajlouni K. M. (2018). The Prevalence and Risk Factors of Peripheral Neuropathy Among Patients with Type 2 Diabetes Mellitus; the Case of Jordan. Diabetol. Metab. Syndr. 10, 8. 10.1186/s13098-018-0309-6", "ArticleIdList": ["10.1186/s13098-018-0309-6", "PMC5822644", "29483946"]}, {"Citation": "Krizova L., Dadakova K., Kasparovska J., Kasparovsky T. (2019). Isoflavones. Mol. 24 (6). 10.3390/molecules24061076", "ArticleIdList": ["10.3390/molecules24061076", "PMC6470817", "30893792"]}, {"Citation": "Larsson J., Bj\u00f6rkdahl A., Esbj\u00f6rnsson E., Sunnerhagen K. S. (2013). Factors Affecting Participation after Traumatic Brain Injury. J. Rehabil. Med. 45 (8), 765\u2013770. 10.2340/16501977-1184", "ArticleIdList": ["10.2340/16501977-1184", "24002312"]}, {"Citation": "Lethaby A. E., Brown J., Marjoribanks J., Kronenberg F., Roberts H., Eden J. (2007). Phytoestrogens for Vasomotor Menopausal Symptoms. Cochrane Database Syst. Rev. 17 (4), CD001395. 10.1002/14651858.CD001395.pub3", "ArticleIdList": ["10.1002/14651858.CD001395.pub3", "17943751"]}, {"Citation": "Levy M., Berson A., Cook T., Bollegala N., Seto E., Tursanski S., et al. (2005). Treatment of Agitation Following Traumatic Brain Injury: a Review of the Literature. NeuroRehabilitation 20 (4), 279\u2013306. 10.3233/nre-2005-20405", "ArticleIdList": ["10.3233/nre-2005-20405", "16403996"]}, {"Citation": "Li C., Li G., Gao Y., Sun C., Wang X. (2016). A 90-day Subchronic Toxicity Study with Sodium Formononetin-3'-Sulphonate (Sul-F) Delivered to Dogs via Intravenous Administration. Regul. Toxicol. Pharmacol. 77, 87\u201392. 10.1016/j.yrtph.2016.02.016", "ArticleIdList": ["10.1016/j.yrtph.2016.02.016", "26924788"]}, {"Citation": "Li G., Yang M., Hao X., Li C., Gao Y., Tao J. (2015). Acute Toxicity of Sodium Formononetin-3'-Sulphonate (Sul-F) in Sprague-Dawley Rats and Beagle Dogs. Regul. Toxicol. Pharmacol. 73 (2), 629\u2013633. 10.1016/j.yrtph.2015.09.010", "ArticleIdList": ["10.1016/j.yrtph.2015.09.010", "26363207"]}, {"Citation": "Li Z., Dong X., Zhang J., Zeng G., Zhao H., Liu Y., et al. (2014). Formononetin Protects TBI Rats against Neurological Lesions and the Underlying Mechanism. J. Neurol. Sci. 338 (1-2), 112\u2013117. 10.1016/j.jns.2013.12.027", "ArticleIdList": ["10.1016/j.jns.2013.12.027", "24411660"]}, {"Citation": "Li Z., Wang Y., Zeng G., Zheng X., Wang W., Ling Y., et al. (2017). Increased miR-155 and Heme Oxygenase-1 Expression Is Involved in the Protective Effects of Formononetin in Traumatic Brain Injury in Rats. Am. J. Transl. Res. 9 (12), 5653\u20135661.", "ArticleIdList": ["PMC5752915", "29312517"]}, {"Citation": "Li Z., Zeng G., Zheng X., Wang W., Ling Y., Tang H., et al. (2018). Neuroprotective Effect of Formononetin against TBI in Rats via Suppressing Inflammatory Reaction in Cortical Neurons. Biomed. Pharmacother. 106, 349\u2013354. 10.1016/j.biopha.2018.06.041", "ArticleIdList": ["10.1016/j.biopha.2018.06.041", "29966980"]}, {"Citation": "Liang K., Ye Y., Wang Y., Zhang J., Li C. (2014). Formononetin Mediates Neuroprotection against Cerebral Ischemia/reperfusion in Rats via Downregulation of the Bax/Bcl-2 Ratio and Upregulation PI3K/Akt Signaling Pathway. J. Neurol. Sci. 344 (1-2), 100\u2013104. 10.1016/j.jns.2014.06.033", "ArticleIdList": ["10.1016/j.jns.2014.06.033", "24996490"]}, {"Citation": "Lima Cavendish R., de Souza Santos J., Belo Neto R., Oliveira Paix\u00e3o A., Val\u00e9ria Oliveira J., Divino de Araujo E., et al. (2015). Antinociceptive and Anti-inflammatory Effects of Brazilian Red Propolis Extract and Formononetin in Rodents. J. Ethnopharmacol. 173, 127\u2013133. 10.1016/j.jep.2015.07.022", "ArticleIdList": ["10.1016/j.jep.2015.07.022", "26192808"]}, {"Citation": "Liu J., Gao L. D., Fu B., Yang H. T., Zhang L., Che S. Q., et al. (2022). Efficacy and Safety of Zicuiyin Decoction on Diabetic Kidney Disease: A Multicenter, Randomized Controlled Trial. Phytomedicine 100, 154079. 10.1016/j.phymed.2022.154079", "ArticleIdList": ["10.1016/j.phymed.2022.154079", "35413644"]}, {"Citation": "Liu N., Yu Z., Gao X., Song Y. S., Yuan J., Xun Y., et al. (2016). Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening. CNS Neurol. Disord. Drug Targets 15 (5), 629\u2013639. 10.2174/1871527315666160321105612", "ArticleIdList": ["10.2174/1871527315666160321105612", "26996171"]}, {"Citation": "Luo L. Y., Fan M. X., Zhao H. Y., Li M. X., Wu X., Gao W. Y. (2018). Pharmacokinetics and Bioavailability of the Isoflavones Formononetin and Ononin and Their In Vitro Absorption in Ussing Chamber and Caco-2 Cell Models. J. Agric. Food Chem. 66 (11), 2917\u20132924. 10.1021/acs.jafc.8b00035", "ArticleIdList": ["10.1021/acs.jafc.8b00035", "29504397"]}, {"Citation": "Messina M. (2010). A Brief Historical Overview of the Past Two Decades of Soy and Isoflavone Research. J. Nutr. 140 (7), 1350S\u20134S. 10.3945/jn.109.118315", "ArticleIdList": ["10.3945/jn.109.118315", "20484551"]}, {"Citation": "Mu H., Bai Y. H., Wang S. T., Zhu Z. M., Zhang Y. W. (2009). Research on Antioxidant Effects and Estrogenic Effect of Formononetin from Trifolium Pratense (Red Clover). Phytomedicine 16 (4), 314\u2013319. 10.1016/j.phymed.2008.07.005", "ArticleIdList": ["10.1016/j.phymed.2008.07.005", "18757188"]}, {"Citation": "Oza M. J., Kulkarni Y. A. (2020). Formononetin Ameliorates Diabetic Neuropathy by Increasing Expression of SIRT1 and NGF. Chem. Biodivers. 17 (6), e2000162. 10.1002/cbdv.202000162", "ArticleIdList": ["10.1002/cbdv.202000162", "32459048"]}, {"Citation": "Polak R., Phillips E. M., Campbell A. (2015). Legumes: Health Benefits and Culinary Approaches to Increase Intake. Clin. Diabetes 33 (4), 198\u2013205. 10.2337/diaclin.33.4.198", "ArticleIdList": ["10.2337/diaclin.33.4.198", "PMC4608274", "26487796"]}, {"Citation": "Rastogi S., Pandey M. M., Rawat A. K. (2016). Traditional Herbs: a Remedy for Cardiovascular Disorders. Phytomedicine 23 (11), 1082\u20131089. 10.1016/j.phymed.2015.10.012", "ArticleIdList": ["10.1016/j.phymed.2015.10.012", "26656228"]}, {"Citation": "Ronis M. J., Little J. M., Barone G. W., Chen G., Radominska-Pandya A., Badger T. M. (2006). Sulfation of the Isoflavones Genistein and Daidzein in Human and Rat Liver and Gastrointestinal Tract. J. Med. Food 9 (3), 348\u2013355. 10.1089/jmf.2006.9.348", "ArticleIdList": ["10.1089/jmf.2006.9.348", "17004897"]}, {"Citation": "Sharma R., Kabra A., Rao M. M., Prajapati P. K. (2018). Herbal and Holistic Solutions for Neurodegenerative and Depressive Disorders: Leads from Ayurveda. Curr. Pharm. Des. 24 (22), 2597\u20132608. 10.2174/1381612824666180821165741", "ArticleIdList": ["10.2174/1381612824666180821165741", "30147009"]}, {"Citation": "Sharma R., Kuca K., Nepovimova E., Kabra A., Rao M. M., Prajapati P. K. (2019). Traditional Ayurvedic and Herbal Remedies for Alzheimer's Disease: from Bench to Bedside. Expert Rev. Neurother. 19 (5), 359\u2013374. 10.1080/14737175.2019.1596803", "ArticleIdList": ["10.1080/14737175.2019.1596803", "30884983"]}, {"Citation": "Sharma R., Garg N., Verma D., Rathi P., Sharma V., Kuca K., et al. (2021). Indian Medicinal Plants as Drug Leads in Neurodegenerative Disorders. Nutraceuticals in Brain Health and Beyond. 2021, 31\u201345. 10.1016/B978-0-12-820593-8.00004-5", "ArticleIdList": ["10.1016/B978-0-12-820593-8.00004-5"]}, {"Citation": "Singh S. P., WahajuddinTewari D., Tewari D., Pradhan T., Jain G. K. (2011). PAMPA Permeability, Plasma Protein Binding, Blood Partition, Pharmacokinetics and Metabolism of Formononetin, a Methoxylated Isoflavone. Food Chem. Toxicol. 49 (5), 1056\u20131062. 10.1016/j.fct.2011.01.012", "ArticleIdList": ["10.1016/j.fct.2011.01.012", "21266188"]}, {"Citation": "Sun M., Zhou T., Zhou L., Chen Q., Yu Y., Yang H., et al. (2012). Formononetin Protects Neurons against Hypoxia-Induced Cytotoxicity through Upregulation of ADAM10 and sA\u03b2PP\u03b1. J. Alzheimers Dis. 28 (4), 795\u2013808. 10.3233/JAD-2011-110506", "ArticleIdList": ["10.3233/JAD-2011-110506", "22085862"]}, {"Citation": "Tay K. C., Tan L. T., Chan C. K., Hong S. L., Chan K. G., Yap W. H., et al. (2019). Formononetin: A Review of its Anticancer Potentials and Mechanisms. Front. Pharmacol. 10, 820. 10.3389/fphar.2019.00820", "ArticleIdList": ["10.3389/fphar.2019.00820", "PMC6676344", "31402861"]}, {"Citation": "Teede H. J., Dalais F. S., Kotsopoulos D., Liang Y. L., Davis S., McGrath B. P. (2001). Dietary Soy Has Both Beneficial and Potentially Adverse Cardiovascular Effects: a Placebo-Controlled Study in Men and Postmenopausal Women. J. Clin. Endocrinol. Metab. 86 (7), 3053\u20133060. 10.1210/jcem.86.7.7645", "ArticleIdList": ["10.1210/jcem.86.7.7645", "11443167"]}, {"Citation": "Upadhyay R. K. (2014). Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier. Biomed. Res. Int. 2014, 869269. 10.1155/2014/869269", "ArticleIdList": ["10.1155/2014/869269", "PMC4127280", "25136634"]}, {"Citation": "Vitale D. C., Piazza C., Melilli B., Drago F., Salomone S. (2013). Isoflavones: Estrogenic Activity, Biological Effect and Bioavailability. Eur. J. Drug Metab. Pharmacokinet. 38 (1), 15\u201325. 10.1007/s13318-012-0112-y", "ArticleIdList": ["10.1007/s13318-012-0112-y", "23161396"]}, {"Citation": "Walle T., Ta N., Kawamori T., Wen X., Tsuji P. A., Walle U. K. (2007). Cancer Chemopreventive Properties of Orally Bioavailable Flavonoids-Mmethylated versus Unmethylated Flavones. Biochem. Pharmacol. 73 (9), 1288\u20131296. 10.1016/j.bcp.2006.12.028", "ArticleIdList": ["10.1016/j.bcp.2006.12.028", "PMC1868573", "17250812"]}, {"Citation": "Wang J., Wang L., Zhou J., Qin A., Chen Z. (2018). The Protective Effect of Formononetin on Cognitive Impairment in Streptozotocin (STZ)-induced Diabetic Mice. Biomed. Pharmacother. 106, 1250\u20131257. 10.1016/j.biopha.2018.07.063", "ArticleIdList": ["10.1016/j.biopha.2018.07.063", "30119194"]}, {"Citation": "Wang Q., Gao S., Zhang W., Zhao Y., He Y., Sun W., et al. (2022). Traditional Use and Safety Evaluation of Combination Traditional Chinese Medicine in European Registration: with XiaoYao Tablets as an Example. Pharmazie 77 (3), 125\u2013130. 10.1691/ph.2022.1227", "ArticleIdList": ["10.1691/ph.2022.1227", "35459442"]}, {"Citation": "Wang X. S., Guan S. Y., Liu A., Yue J., Hu L. N., Zhang K., et al. (2019). Anxiolytic Effects of Formononetin in an Inflammatory Pain Mouse Model. Mol. Brain 12 (1), 36. 10.1186/s13041-019-0453-4", "ArticleIdList": ["10.1186/s13041-019-0453-4", "PMC6454770", "30961625"]}, {"Citation": "Wu Q.-L., Cheng Y.-Q., Liu A.-J., Zhang W.-D. (2020). Formononetin Recovered Injured Nerve Functions by Enhancing Synaptic Plasticity in Ischemic Stroke Rats. Biochem. Biophysical Res. Commun. 525, 67\u201372. 10.1016/j.bbrc.2020.02.015", "ArticleIdList": ["10.1016/j.bbrc.2020.02.015", "32081422"]}, {"Citation": "Yan X., Wang S., Yu A., Shen X., Zheng H., Wang L. (2019). Cell Chromatography-Based Screening of the Active Components in Buyang Huanwu Decoction Promoting Axonal Regeneration. Biomed. Res. Int. 2019, 6970198. 10.1155/2019/6970198", "ArticleIdList": ["10.1155/2019/6970198", "PMC6791218", "31662991"]}, {"Citation": "Yankner B. A., Duffy L. K., Kirschner D. A. (1990). Neurotrophic and Neurotoxic Effects of Amyloid Beta Protein: Reversal by Tachykinin Neuropeptides. Science 250 (4978), 279\u2013282. 10.1126/science.2218531", "ArticleIdList": ["10.1126/science.2218531", "2218531"]}, {"Citation": "Ye Y. B., Tang X. Y., Verbruggen M. A., Su Y. X. (2006). Soy Isoflavones Attenuate Bone Loss in Early Postmenopausal Chinese Women : a Single-Blind Randomized, Placebo-Controlled Trial. Eur. J. Nutr. 45 (6), 327\u2013334. 10.1007/s00394-006-0602-2", "ArticleIdList": ["10.1007/s00394-006-0602-2", "16763748"]}, {"Citation": "Yu D., Duan Y., Bao Y., Wei C., An L. (2005). Isoflavonoids from Astragalus mongholicus Bunge Protect PC12 Cells from Toxicity Induced by L-Glutamate. J. Ethnopharmacol. 98 (1-2), 89\u201394. 10.1016/j.jep.2004.12.027", "ArticleIdList": ["10.1016/j.jep.2004.12.027", "15763368"]}, {"Citation": "Yu D. H., Bao Y. M., An L. J., Yang M. (2009). Protection of PC12 Cells against Superoxide-Induced Damage by Isoflavonoids from Astragalus mongholicus Bunge. Biomed. Environ. Sci. 22 (1), 50\u201354. 10.1016/S0895-3988(09)60022-2", "ArticleIdList": ["10.1016/S0895-3988(09)60022-2", "19462688"]}, {"Citation": "Yu L., Zhang Y., Chen Q., He Y., Zhou H., Wan H., et al. (2022). Formononetin Protects against Inflammation Associated with Cerebral Ischemia-Reperfusion Injury in Rats by Targeting the JAK2/STAT3 Signaling Pathway. Biomed. Pharmacother. 149, 112836. 10.1016/j.biopha.2022.112836", "ArticleIdList": ["10.1016/j.biopha.2022.112836", "35339827"]}, {"Citation": "Zhang C., Zhu L., Lu S., Li M., Bai M., Li Y., et al. (2022). The Antidepressant-like Effect of Formononetin on Chronic Corticosterone-Treated Mice. Brain Res. 1783, 147844. 10.1016/j.brainres.2022.147844", "ArticleIdList": ["10.1016/j.brainres.2022.147844", "35218705"]}, {"Citation": "Zhang L., Zuo Z., Lin G. (2007). Intestinal and Hepatic Glucuronidation of Flavonoids. Mol. Pharm. 4 (6), 833\u2013845. 10.1021/mp700077z", "ArticleIdList": ["10.1021/mp700077z", "17979245"]}, {"Citation": "Zhang W., Zhu J. H., Xu H., Huang X. P., Liu X. D., Deng C. Q. (2019). Five Active Components Compatibility of Astragali Radix and Angelicae Sinensis Radix Protect Hematopoietic Function against Cyclophosphamide-Induced Injury in Mice and T-BHP-Induced Injury in HSCs. Front. Pharmacol. 10, 936. 10.3389/fphar.2019.00936", "ArticleIdList": ["10.3389/fphar.2019.00936", "PMC6735167", "31551766"]}, {"Citation": "Zhu H., Zou L., Tian J., Lin F., He J., Hou J. (2014). Protective Effects of Sulphonated Formononetin in a Rat Model of Cerebral Ischemia and Reperfusion Injury. Planta Med. 80 (4), 262\u2013268. 10.1055/s-0033-1360340", "ArticleIdList": ["10.1055/s-0033-1360340", "24549929"]}, {"Citation": "Zlokovic B. V. (2005). Neurovascular Mechanisms of Alzheimer's Neurodegeneration. Trends Neurosci. 28 (4), 202\u2013208. 10.1016/j.tins.2005.02.001", "ArticleIdList": ["10.1016/j.tins.2005.02.001", "15808355"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "28"}, {"Year": "2022", "Month": "5", "Day": "16"}, {"Year": "2022", "Month": "6", "Day": "17", "Hour": "2", "Minute": "46"}, {"Year": "2022", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "18", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "5", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["35712702", "PMC9196267", "10.3389/fphar.2022.905898", "905898"]}}], "PubmedBookArticle": []}